WELLSITA-M

Sitagliptin & Metformin Tablets

Description:
WELLSITA-M is a modern dual-action anti-diabetic formulation that combines Sitagliptin Phosphate and Metformin Hydrochloride for effective control of Type 2 Diabetes Mellitus. It works by enhancing insulin secretion, improving glucose utilization, and reducing glucose production in the liver — resulting in better glycemic control and long-term diabetes management.

Key Benefits:
✅ Provides dual mechanism control of blood sugar levels
✅ Enhances natural insulin secretion in response to meals
✅ Reduces hepatic glucose production
✅ Helps maintain HbA1c within target range
✅ Supports weight management and reduces risk of hypoglycemia

Composition (Each Film-Coated Tablet Contains):

Sitagliptin Phosphate IP equivalent to Sitagliptin 50 mg
Metformin Hydrochloride IP 500 mg / 1000 mg (depending on variant)

Dosage:
As directed by a registered medical practitioner.

Packaging:
2×15 Tablets (Alu-Alu pack)

Manufacturer:
Scythian Healthcare

WELLSITA-M Tablets combine Sitagliptin & Metformin Tablets to improve glycemic control in adults with Type 2 Diabetes Mellitus. This combination is ideal for patients whose blood sugar is not adequately managed by Metformin alone.

Therapeutic Uses: